According to Zhitong Finance APP, Tibet Aim Pharm. Inc. (002826.SZ) disclosed the 2024 restrictive stock incentive plan (draft), proposing to grant a total of 4.86 million shares of restrictive stocks to the incentive objects, accounting for approximately 2.55% of the company's total share capital on the date of the announcement of the incentive plan draft. Among them, the first grant of restrictive stocks is 4.5 million shares, with a total of 35 incentive objects for the first grant, at a granting price of 6.45 yuan/share.